Products for Research Use Only
RegisterLogin

Nepuvibart

CAT: 0931-T74425-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0931-T74425-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
2640224-48-0
Target
SARS-CoV
Related Pathways
Microbiology/Virology
Bioactivity
Nepuvibart (ZRC3308-B10), an IgG1 type anti-SARS-CoV-2 monoclonal antibody, exhibits strong binding affinity to a distinct non-competing epitope on the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein. When combined in a 1:1 ratio with ZRC3308-A7, Nepuvibart is effective in preventing COVID-19 and in treating the early stages of the disease before it progresses to severe illness [1].
Shipping Conditions
Ice Packs
Storage Temperature
-20°C

Alternative Products

CatalogName
HY-145643Nepuvibart
GTR18338049-01Nepuvibart Antibody
ICH5707-20mgNepuvibart Biosimilar - Research Grade
GTR18780189-01(Nepuvibart) Biosimilar Reference Antibody
MBS1564041-01Research Grade Nepuvibart
E55B0886Nepuvibart (Reference antibody)
GTR18697218-01Nepuvibart Human Monoclonal Antibody
A135618Nepuvibart Biosimilar (Monoclonal, IgG1, kappa)
RA0657-01Nepuvibart (Biosimilar Reference Antibody) (SARS-CoV-2 Spike RBD)
PX-TA1869-01Nepuvibart Biosimilar - Anti-SARS-CoV-2 Spike RBD mAb - Research Grade

Popular Products